↓ Skip to main content

A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis

Overview of attention for article published in Arthritis Research & Therapy, October 2013
Altmetric Badge

Citations

dimensions_citation
95 Dimensions

Readers on

mendeley
96 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis
Published in
Arthritis Research & Therapy, October 2013
DOI 10.1186/ar4347
Pubmed ID
Authors

David A Martin, Melvin Churchill, Luis Felipe Flores-Suarez, Mario H Cardiel, Daniel Wallace, Richard Martin, Kristine Phillips, Jeffrey L Kaine, Hua Dong, David Salinger, Erin Stevens, Chris B Russell, James B Chung

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Japan 1 1%
Italy 1 1%
Australia 1 1%
Unknown 92 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 16%
Student > Ph. D. Student 11 11%
Student > Master 11 11%
Student > Doctoral Student 7 7%
Other 7 7%
Other 15 16%
Unknown 30 31%
Readers by discipline Count As %
Medicine and Dentistry 28 29%
Immunology and Microbiology 7 7%
Agricultural and Biological Sciences 7 7%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Biochemistry, Genetics and Molecular Biology 2 2%
Other 10 10%
Unknown 36 38%